An anti-coronavirus drug is developed by the Defence Research and Development Organization (DRDO) and will be launched tomorrow. It will be launched with the Union Defence Minister Rajnath Singh distributing around 10,000 doses of the same to some hospitals in the national capital.
The drug is called 2-deoxy-D-glucose or 2-DG and was developed by a DRDO lab in collaboration with Hyderabad-based pharma company, Dr. Reddy’s Laboratories. The country’s top drug regulator, Drugs Controller General of India (DCGI), has approved the medicine for emergency use.
The drug has shown excellent results in its phase 2 and phase 3 clinical trials. The medicine was developed to be safe for COVID-19 patients in phase 2 trials which was conducted between May and October. It was also found that it is successful in cutting short the hospital stays of patients and reducing supplemental use of oxygen.
Discussion about this post